Bachur NR - Search Results

1

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.

Benjamin RS, Wiernik PH, Bachur NR. Benjamin RS, et al. Among authors: bachur nr. Cancer. 1974 Jan;33(1):19-27. doi: 10.1002/1097-0142(197401)33:1<19::aid-cncr2820330107>3.0.co;2-m. Cancer. 1974. PMID: 4810094 No abstract available.

2

Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.

Benjamin RS, Riggs CE Jr, Bachur NR. Benjamin RS, et al. Among authors: bachur nr. Cancer Res. 1977 May;37(5):1416-20. Cancer Res. 1977. PMID: 856462

3

High-dose daunorubicin therapy for acute nonlymphocytic leukemia: correlation of response and toxicity with pharmacokinetics and intracellular daunorubicin reductase activity.

Greene W, Huffman D, Wiernik PH, Schimpff S, Benjamin R, Bachur N. Greene W, et al. Cancer. 1972 Dec;30(6):1419-27. doi: 10.1002/1097-0142(197212)30:6<1419::aid-cncr2820300602>3.0.co;2-i. Cancer. 1972. PMID: 4264560 No abstract available.

4

High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy.

Ostrow S, Egorin M, Aisner J, Bachur N, Wiernik PH. Ostrow S, et al. Cancer Clin Trials. 1980 Spring;3(1):23-7. Cancer Clin Trials. 1980. PMID: 7190082

5

Acute doxorubicin toxicity. Relationship to pretreatment liver function, response, and pharmacokinetics in patients with acute nonlymphocytic leukemia.

Brenner DE, Wiernik PH, Wesley M, Bachur NR. Brenner DE, et al. Among authors: bachur nr. Cancer. 1984 Mar 1;53(5):1042-8. doi: 10.1002/1097-0142(19840301)53:5<1042::aid-cncr2820530505>3.0.co;2-b. Cancer. 1984. PMID: 6692298

6

Cis-Dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasms.

Ostrow S, Egorin MJ, Hahn D, Markus S, Leroy A, Chang P, Klein M, Bachur NR, Wiernik PH. Ostrow S, et al. Among authors: bachur nr. Cancer. 1980 Oct 15;46(8):1715-21. doi: 10.1002/1097-0142(19801015)46:8<1715::aid-cncr2820460802>3.0.co;2-h. Cancer. 1980. PMID: 7191768

7

Pharmacokinetics and metabolism of adriamycin in man.

Benjamin RS, Riggs CE Jr, Bachur NR. Benjamin RS, et al. Among authors: bachur nr. Clin Pharmacol Ther. 1973 Jul-Aug;14(4):592-600. doi: 10.1002/cpt1973144part1592. Clin Pharmacol Ther. 1973. PMID: 4723268 No abstract available.

8

Adriamycin.

Benjamin RS, Wiernik PH, Bachur NR. Benjamin RS, et al. Among authors: bachur nr. Ann Intern Med. 1974 Sep;81(3):414-5. doi: 10.7326/0003-4819-81-3-414. Ann Intern Med. 1974. PMID: 4850444 No abstract available.

9

Adriamycin: a new effective agent in the therapy of disseminated sarcomas.

Benjamin RS, Wiernik PH, Bachur NR. Benjamin RS, et al. Among authors: bachur nr. Med Pediatr Oncol. 1975;1(1):63-76. doi: 10.1002/mpo.2950010109. Med Pediatr Oncol. 1975. PMID: 1232527

10

Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma.

Fuks JZ, Egorin MJ, Aisner J, Van Echo DA, Ostrow S, Bachur NR, Wiernik PH. Fuks JZ, et al. Among authors: bachur nr. Cancer Chemother Pharmacol. 1983;10(2):104-8. doi: 10.1007/BF00446219. Cancer Chemother Pharmacol. 1983. PMID: 6299598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page